Bio-Techne Corp [NASDAQ: TECH] jumped around 1.03 points on Thursday, while shares priced at $49.78 at the close of the session, up 2.11%.
Compared to the average trading volume of 2.05M shares, TECH reached a trading volume of 4406198 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Bio-Techne Corp [TECH]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TECH shares is $71.91 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TECH stock is a recommendation set at 1.78. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
KeyBanc Capital Markets have made an estimate for Bio-Techne Corp shares, keeping their opinion on the stock as Sector Weight, with their previous recommendation back on April 09, 2025. While these analysts kept the previous recommendation, Evercore ISI raised their target price to Outperform. The new note on the price target was released on March 18, 2025, representing the official price target for Bio-Techne Corp stock. Previously, the target price had yet another drop from $88 to $68, while Robert W. Baird kept a Neutral rating on TECH stock.
The Average True Range (ATR) for Bio-Techne Corp is set at 2.61, with the Price to Sales ratio for TECH stock in the period of the last 12 months amounting to 6.51. The Price to Book ratio for the last quarter was 3.78, with the Price to Cash per share for the same quarter was set at 0.89. Price to Free Cash Flow for TECH in the course of the last twelve months was 35.65 with Quick ratio for the last quarter at 2.58.
How has TECH stock performed recently?
Bio-Techne Corp [TECH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.30. With this latest performance, TECH shares gained by 1.99% in over the last four-week period, additionally sinking by -34.41% over the last 6 months – not to mention a drop of -34.55% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TECH stock in for the last two-week period is set at 43.61, with the RSI for the last a single of trading hit 46.97, and the three-weeks RSI is set at 41.76 for Bio-Techne Corp [TECH]. The present Moving Average for the last 50 days of trading for this stock 55.54, while it was recorded at 49.31 for the last single week of trading, and 69.15 for the last 200 days.
Bio-Techne Corp [TECH]: Deeper insight into the fundamentals
Bio-Techne Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.58 and a Current Ratio set at 3.71.
Earnings analysis for Bio-Techne Corp [TECH]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TECH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bio-Techne Corp go to 11.50%.
Insider trade positions for Bio-Techne Corp [TECH]
The top three institutional holders of TECH stocks are: VANGUARD GROUP INC with ownership of 18.18 million shares, which is approximately 11.5171%. BLACKROCK INC., holding 14.99 million shares of the stock with an approximate value of $$1.07 billion in TECH stocks shares; and BLACKROCK INC., currently with $$610.87 million in TECH stock with ownership which is approximately 5.4006%.
